Lipum AB (Sweden) Today
| LIPUM Stock | SEK 13.90 0.30 2.11% |
Performance0 of 100
| Odds Of DistressLess than 25
|
Lipum AB is selling for under 13.90 as of the 31st of January 2025; that is 2.11 percent decrease since the beginning of the trading day. The stock's lowest day price was 13.8. Lipum AB has about a 25 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 11th of February 2023 and ending today, the 31st of January 2025. Click here to learn more.
Lipum AB , a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. The company was founded in 2010 and is headquartered in Ume, Sweden. Lipum AB is traded on Stockholm Stock Exchange in Sweden. The company has 7.65 M outstanding shares. More on Lipum AB
Moving against Lipum Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Lipum Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Lipum AB's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Lipum AB or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Lipum AB (LIPUM) is traded on Stockholm Exchange in Sweden and employs 5 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 104.07 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lipum AB's market, we take the total number of its shares issued and multiply it by Lipum AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Lipum AB operates under Healthcare sector and is part of Biotechnology industry. The entity has 7.65 M outstanding shares.
Lipum AB generates negative cash flow from operations
Check Lipum AB Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Lipum AB is kr104.07 Million. Lipum AB secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 81.67 % of Lipum AB outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Lipum Ownership Details
Lipum AB Risk Profiles
Although Lipum AB's alpha and beta are two of the key measurements used to evaluate Lipum AB's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.38 | |||
| Standard Deviation | 3.52 | |||
| Variance | 12.38 | |||
| Risk Adjusted Performance | (0.0003) |
Lipum Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Lipum AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Lipum AB Corporate Management
Elected by the shareholders, the Lipum AB's board of directors comprises two types of representatives: Lipum AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lipum. The board's role is to monitor Lipum AB's management team and ensure that shareholders' interests are well served. Lipum AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lipum AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pernilla Abrahamsson | Chief Officer | Profile | |
| Associate Lindquist | CoFounder Research | Profile | |
| Pr Hernell | CoFounder Director | Profile | |
| Marina Norberg | Chief Officer | Profile | |
| Einar Ponten | Chief Officer | Profile |
Additional Tools for Lipum Stock Analysis
When running Lipum AB's price analysis, check to measure Lipum AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipum AB is operating at the current time. Most of Lipum AB's value examination focuses on studying past and present price action to predict the probability of Lipum AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipum AB's price. Additionally, you may evaluate how the addition of Lipum AB to your portfolios can decrease your overall portfolio volatility.